Eurofins-Cerep SA (ALECR)

Currency in EUR
17,600.0
0.0(0.00%)
Real-time Data·
ALECR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ALECR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17,600.017,600.0
52 wk Range
15,800.021,800.0
Key Statistics
Prev. Close
17,600
Open
17,600
Day's Range
17,600-17,600
52 wk Range
15,800-21,800
Volume
-
Average Volume (3m)
5
1-Year Change
-10.66%
Book Value / Share
14,222.85
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALECR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Eurofins-Cerep SA Company Profile

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company’s research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France. Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.

Employees
207
Market
France

Compare ALECR to Peers and Sector

Metrics to compare
ALECR
Peers
Sector
Relationship
P/E Ratio
12.4x−4.4x−0.5x
PEG Ratio
-0.070.00
Price/Book
1.2x1.8x2.6x
Price / LTM Sales
2.2x2.1x3.3x
Upside (Analyst Target)
-45.6%42.8%
Fair Value Upside
Unlock14.8%6.5%Unlock

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
20.60M / --
EPS Revisions
Last 90 days

ALECR Income Statement

People Also Watch

64.72
EUFI
-2.82%
59.70
AKE
+1.79%
86.20
GPIF
-0.23%
121.35
SGEF
+0.62%
25.58
RXL
+0.47%

FAQ

What Stock Exchange Does Eurofins-Cerep Trade On?

Eurofins-Cerep is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Eurofins-Cerep?

The stock symbol for Eurofins-Cerep is "ALECR."

What Is the Eurofins-Cerep Market Cap?

As of today, Eurofins-Cerep market cap is 88.77M.

What Is Eurofins-Cerep's Earnings Per Share (TTM)?

The Eurofins-Cerep EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is ALECR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Eurofins-Cerep Stock Split?

Eurofins-Cerep has split 3 times.

How Many Employees Does Eurofins-Cerep Have?

Eurofins-Cerep has 207 employees.

What is the current trading status of Eurofins-Cerep (ALECR)?

As of 06 Aug 2025, Eurofins-Cerep (ALECR) is trading at a price of 17,600.00, with a previous close of 17,600.00. The stock has fluctuated within a day range of 17,600.00 to 17,600.00, while its 52-week range spans from 15,800.00 to 21,800.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.